Cefotiam hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefotiam hydrochloride and what is the scope of freedom to operate?
Cefotiam hydrochloride
is the generic ingredient in one branded drug marketed by Takeda and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for cefotiam hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 2 |
Patent Applications: | 5,028 |
Formulation / Manufacturing: | see details |
DailyMed Link: | cefotiam hydrochloride at DailyMed |
Recent Clinical Trials for cefotiam hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Senosiain, S.A. de C.V. | Phase 2 |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 2 |
Shanghai Zhongshan Hospital | N/A |
Medical Subject Heading (MeSH) Categories for cefotiam hydrochloride
US Patents and Regulatory Information for cefotiam hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda | CERADON | cefotiam hydrochloride | INJECTABLE;INJECTION | 050601-001 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |